Jun 28, 2023, 17:38
ADCs keep showing impressive activity across cancers – Paolo Tarantino
ADCs keep showing impressive activity across cancers. 1L EV+pembro led to 64% ORR among patients with advanced urothelial cancer. Still, the 3.9% rate of fatal TRAEs calls for strategies to optimize the toxicities of ADCs, particularly when used in combos.
For details: Click here
Source: Paolo Tarantino/Twitter